BioCardia (BCDA) Revenue Growth (5y) (2016 - 2024)
Powered by 
Analysis
BioCardia (BCDA) Revenue Growth (5y) (2016 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.23 Bn | 9.39 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.02 Bn | 5.02 Bn | - |
| 3 | Iovance Biotherapeutics | 3.67 Bn | 3.37 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.55 Bn | 2.58 Bn | 251.50 Mn |
| 5 | uniQure | 3.00 Bn | 3.00 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - |
| 7 | Precigen | 2.36 Bn | 2.36 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.36 Bn | 251.87 Mn |
| 9 | Vericel | 1.95 Bn | 1.79 Bn | 56.40 Mn |
| 10 | BioCardia | 13.06 Mn | 8.94 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | -48.89% |
| Mar 31, 2024 | -23.94% |
| Dec 31, 2023 | -33.90% |
| Sep 30, 2023 | 33.56% |
| Jun 30, 2023 | -29.04% |
| Mar 31, 2023 | -20.30% |
| Dec 31, 2022 | 1.17% |
| Sep 30, 2022 | 10.28% |
| Jun 30, 2022 | 54.12% |
| Mar 31, 2022 | -15.22% |
| Dec 31, 2021 | -10.43% |
| Sep 30, 2021 | 47.65% |
| Jun 30, 2021 | -13.68% |
| Mar 31, 2021 | -23.71% |
| Jun 30, 2018 | 28.21% |
| Mar 31, 2018 | 39.26% |
| Dec 31, 2017 | 46.14% |
| Sep 30, 2017 | 46.91% |
| Jun 30, 2017 | 45.80% |
| Mar 31, 2017 | 65.60% |